NDC 50633-220 – Vistogard

Uridine Triacetate 951 mg/g · Granule · Oral

Human Prescription Drug

Product NDC50633-220

Product details

Brand name
Vistogard
Generic name
Uridine triacetate
Labeler
BTG International Inc
Dosage form
Granule
Route
Oral
Marketing category
NDA · NDA208159
Marketed since
July 31, 2024
Listing expires
December 31, 2027
Pharmacologic class
Pyrimidine Analog

Active ingredients

Uses, dosage, side effects and warnings for Vistogard →

Package NDC codes (2)

Package NDCDescriptionSince
50633-220-044 PACKET in 1 CARTON (50633-220-04) / 10 g in 1 PACKET (50633-220-10)Jul 31, 2024
50633-220-2020 PACKET in 1 CARTON (50633-220-20) / 10 g in 1 PACKET (50633-220-10)Jul 31, 2024